Publication | Open Access
Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an alzheimer's disease model mouse
168
Citations
32
References
2010
Year
Even short term treatment with monoclonal antibodies such as 6D11 or other compounds which block the binding of Aβ oligomers to PrPC can be used to treat cognitive deficits in aged AD transgenic mice.
| Year | Citations | |
|---|---|---|
Page 1
Page 1